BCTX Latest Headlines

BriaCell’s Phase 3 Breast Cancer Trial Named a 2026 ‘Clinical Trial to Watch’ by Nature Medicine

at www.tipranks.com (Thu, 18-Dec 8:27 AM)

BriaCell's Bria-IMT Regimen Shows Meaningful Survival Benefits and Predictive Biomarker Potential in Metastatic Breast Cancer

Market Chameleon (Wed, 10-Dec 8:18 AM)

BriaCell Expands Phase 3 Metastatic Breast Cancer Study With Major New Clinical Sites

Market Chameleon (Tue, 21-Oct 8:25 AM)